Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
SC Pianificazione, Programmazione e Controllo Direzionale, Azienda Regionale di Coordinamento per la Salute, Udine, Italy.
Tumori. 2023 Aug;109(4):406-412. doi: 10.1177/03008916221128343. Epub 2022 Oct 10.
To describe the practice of prostate-specific antigen (PSA) testing over more than 20 years in Friuli Venezia Giulia (FVG), North-Eastern Italy.
A population-based, ecological study was conducted using information derived from regional administrative health-related databases. Data on PSA and prostate biopsies performed on resident men aged ⩾45 years from 1998 to 2019 were retrieved. PSA and biopsy rates were calculated as the number of men who had at least one such procedure in each calendar year over the mean resident male population of the same year. Temporal trends were analyzed using joinpoint regression (annual percentage change -APC).
A total of 2,502,670 PSA were made between 1998 to 2019 in men aged ⩾45 years. The number of PSA steadily increased from 51,055 in 1998-1999 to 134,504 in 2010-2011, then dropped to 122,080 in 2018-2019. Significant changes in the slopes of PSA rates emerged in 2002 and 2009: the largest increase occurred during 1998-2002 (APC 18.4), followed by a smaller increase in 2002-2009 (APC 3.4) and a subsequent reduction (APC -2.5). Similar patterns emerged for all ages, but the decrease since 2009 was smaller for men aged ⩾65 years. An upward trend emerged in biopsy rate from 1998 to 2001 (APC 13.0), followed by a smaller increase until 2007 (APC 5.7) and a subsequent decrease. Biopsies as percentage of PSA decreased from 3.2% to 2.2%, particularly in those aged ⩾75 years.
Although overall declining PSA rates have been observed in FVG since 2009, rates remained higher in the ⩾65-year-old group than in the 45-64-year-old group.
描述过去 20 多年来在意大利东北部弗留利-威尼斯朱利亚地区(简称 FVG)进行前列腺特异性抗原(PSA)检测的实践情况。
本研究采用基于人群的生态研究方法,利用从区域行政卫生相关数据库中提取的数据进行研究。检索了 1998 年至 2019 年期间 45 岁及以上居民男性进行的 PSA 和前列腺活检的数据。PSA 和活检的比率是根据当年具有至少一次此类程序的男性人数除以同年常驻男性人口数计算得出的。使用 Joinpoint 回归(年度百分比变化率-APC)分析时间趋势。
1998 年至 2019 年间,45 岁及以上男性共进行了 2502670 次 PSA 检测。PSA 检测数量从 1998-1999 年的 51055 例稳步增加到 2010-2011 年的 134504 例,然后在 2018-2019 年降至 122080 例。PSA 检测率的斜率在 2002 年和 2009 年出现了显著变化:最大的增长率发生在 1998-2002 年(APC18.4%),其次是 2002-2009 年的较小增长率(APC3.4%)和随后的减少(APC-2.5%)。所有年龄段都出现了类似的模式,但自 2009 年以来,65 岁以上男性的下降幅度较小。活检率从 1998 年至 2001 年呈上升趋势(APC13.0%),随后在 2007 年之前略有增加(APC5.7%),随后下降。PSA 检测中活检的比例从 3.2%降至 2.2%,特别是在 75 岁以上人群中。
尽管自 2009 年以来,FVG 的总体 PSA 检测率一直在下降,但在 65 岁以上人群中的比率仍高于 45-64 岁人群。